1. Sichuan Huafeng’s Stagnation: A Case Study in Corporate Inefficiency

Sichuan Huafeng (688629.SS) closed the trading day flat, trading 0 % over the 24‑hour window that ended at 01:37 PM Central Europe on Wednesday 21 st. At the moment, a share of the company can be bought for approximately CNY 80.15 on the major exchanges, yet the stock’s liquidity is a mirage: the current supply hovers at a staggering 468.3 million shares, while the market capitalisation stubbornly remains at CNY 37.5 bn. In the last 24 hours, the company’s shares traded a modest CNY 980.9 mn, a figure that is paltry when measured against the backdrop of its 200‑day moving average, which sits at an eye‑watering CNY 140.27.

This disparity between price and value is not a one‑off blip. Since the end of last month, Sichuan Huafeng has slumped by a disquieting ‑37.09 %. Even the most optimistic technical indicator – the 200‑day SMA – refuses to offer any solace, standing far above the current trading price. The company’s all‑time high of CNY 228.16 (10 July 2026) and the 52‑week low of CNY 69.8 (12 November 2025) illustrate a dramatic range, yet the current price remains trapped in the lower echelons of that spectrum, suggesting a lack of investor confidence and an erosion of intrinsic value.

2. A Comparative Landscape: What the Benchmarks Reveal

  • Shenzhen Kaifa (000021.SZ): Flat at 0 %, trading at CNY 28.88. Market cap CNY 44.5 bn; P/E 36.69.
  • Shandong Himile Mechanical (002595.SZ): Flat at 0 %, trading at CNY 38.95. Market cap CNY 44.7 bn; P/E 19.66.
  • China Nonferrous Mining (1258.HK): Down ‑4.68 %, trading at HKD 13.41. Market cap HKD 52.5 bn; P/E 12.37.
  • Shanghai Lujiazui Fin&Trad (600663.SS): Flat at 0 %, trading at CNY 8.94. Market cap CNY 44.9 bn; P/E 28.85.

These peers, while not immune to market turbulence, demonstrate that a flat or modestly declining price is not an inherent flaw. Instead, it is a symptom of strategic missteps or inadequate corporate governance that have left Sichuan Huafeng’s valuation in limbo.

3. Regulatory Context: The Rise of Active ETFs

On 19 October, China’s securities regulator approved the first batch of 18 actively managed ETFs, expanding the public fund landscape. These funds—balanced, value, dividend, quality, and growth—promise a more flexible, research‑driven alternative to index funds. They must hold a diversified portfolio of at least thirty securities, with no single holding exceeding sixty per cent, ensuring transparency and mitigating concentration risk. This regulatory shift is part of a broader policy that prioritises professional research, cost efficiency, and long‑term investor returns. While this development may benefit the market as a whole, Sichuan Huafeng has yet to leverage this opportunity to signal strategic renewal or to attract new capital.

4. Financing Momentum on the Science & Technology Innovation Board

The China Science and Technology Innovation Board has witnessed a surge in financing balances, with an increase of over six billion yuan compared to the previous day. Technology names, especially in electronics, have drawn substantial net purchases, reflecting investor confidence in the sector. Institutional buyers appear to maintain a positive stance on high‑growth firms, but the board’s activity remains mixed. Sichuan Huafeng, listed on the same board, has not demonstrated a comparable influx of capital, underscoring its stagnant trajectory.

5. The Bottom Line: Why Sichuan Huafeng’s Performance is Alarming

  • Market Value vs. Technical Indicators: A 200‑day SMA of CNY 140.27 versus a trading price of CNY 80.15 signals a severe undervaluation or a fundamental flaw.
  • Consistent Decline: A ‑37.09 % drop since last month’s close is not a minor dip but a systemic erosion of shareholder value.
  • Lack of Strategic Innovation: No evidence of capital allocation into high‑growth sectors or adoption of new financial instruments (e.g., active ETFs).
  • Investor Confidence: Flat trading and modest turnover suggest waning interest, especially when compared to peers with similar market caps.

In an era where market dynamics reward agility, transparency, and strategic foresight, Sichuan Huafeng’s stagnant performance is a stark reminder that corporate inertia can rapidly erode value. Stakeholders must demand decisive action—whether through restructuring, capital re‑allocation, or strategic partnerships—to reverse this downward spiral and restore investor confidence.